STAT Plus: Pharmalittle: FDA sets Covid-19 vaccine guidance; White House grabs much of the remdesivir supply
Rise and shine, everyone, another busy day is on the way. Yes, indeed, the middle of the week is already here, which means there is much to do. No doubt, you can relate on some level. So please join us as we grab a cup of stimulation — we are sticking with maple bourbon for the moment — and tackle the Zoom and Skype calls that are piling up. Meanwhile, here is the latest grab bag of items of interest to help you along. Hope you conquer the world today, such as it is, and do stay in touch …
The Food and Drug Administration released guidance for approving a Covid-19 vaccine, saying the vaccine has to prevent or decrease disease severity in at least 50% of people who are inoculated, Reuters informs us. “The guidelines are pretty standard, they look pretty much like influenza vaccine guidelines,” says Gregory Poland, director of Mayo Vaccine Research Group. “I don’t think that’s a high bar. I think that’s a low to maybe an appropriate bar for a first-generation Covid-19 vaccine.”
Continue to STAT Plus to read the full story…
